Polymorphism at position-308 of the promoter of the tumor necrosis factor α gene and infliximab therapy in rheumatoid arthritis.

被引：0
|
作者：
Fonseca, JE
Carvalho, T
Cruz, M
Nero, P
Sobral, M
Mourao, AF
Cavaleiro, J
Carmo-Fonseca, M
Branco, J
机构：
[1] Inst Mol Med, Lisbon, Portugal
[2] Hosp Egas Moniz, Lisbon, Portugal
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S394 / S394
页数：1
相关论文
共 50 条
  • [1] Polymorphism at position-308 of the tumor necrosis factor a gene influences outcome of infliximab therapy in rheumatoid arthritis
    Mugnier, B
    Balandraud, N
    Darque, A
    Roudier, C
    Roudier, J
    Reviron, D
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (07): : 1849 - 1852
  • [2] Polymorphism at position-308 of the tumour necrosis factor α gene and rheumatoid arthritis pharmacogenetics
    Fonseca, JE
    Carvalho, T
    Cruz, M
    Nero, P
    Sobral, M
    Mourao, AF
    Cavaleiro, J
    Ligeiro, D
    Abreu, I
    Carmo-Fonseca, M
    Branco, JC
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (05) : 793 - 794
  • [3] Polymorphism at position-308 of TNFalfa gene influences outcome of infliximab therapy in rheumatoid arthritis
    Mugnierl, B
    Balandraud, N
    Roudier, C
    Roudier, J
    Reviron, D
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 190 - 190
  • [4] Association between tumor necrosis factor-alpha gene promoter polymorphism at position-308 and acne in Turkish patients
    Baz, Kiymet
    Erdal, M. Emin
    Yazici, Ayca Cordan
    Soylemez, Fatma
    Guvenc, Ulas
    Tasdelen, Bahar
    Ikizoglu, Gueliz
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 2008, 300 (07) : 371 - 376
  • [5] Polymorphism in the TNF promoter gene (-308A) correlates with worse response to infliximab in rheumatoid arthritis.
    Pinto, JA
    Mosquera, A
    Freire, M
    Rego, I
    Lopez-Armada, MJ
    Maneiro, E
    Galdo, F
    Fernández-García, JL
    Blanco, FJ
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S399 - S399
  • [6] Tumor necrosis factor-α promoter polymorphism at position-308 predicts response to combination therapy in hepatitis C virus infection
    Dai, CY
    Chuang, WL
    Chang, WY
    Chen, SC
    Lee, LP
    Hsieh, MY
    Hou, NJ
    Lin, ZY
    Huang, JF
    Hsieh, MY
    Wang, LY
    Yu, ML
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (01): : 98 - 101
  • [7] Tumour necrosis factor alpha promoter polymorphism at position-308 is not associated with actinic prurigo
    Grabczynska, SA
    Carey, BS
    McGregor, JM
    Hawk, JLM
    Vaughan, RW
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2001, 26 (08) : 700 - 704
  • [8] -308 A/G polymorphism in the tumor necrosis factor-α gene influences outcome of etanercept treatment in rheumatoid arthritis.
    Guis, Sandrine, Sr.
    Balandraud, Nathalie
    Bouvenot, Julien
    Auger, Isabelle
    Mugnier, Benedicte
    Toussirot, Eric
    Wendling, Daniel
    Mattei, Jean Pierre
    Tomachot, Benoit
    Legeron, Pierre
    Landt, Olfert
    Roudier, Jean
    Roudier, Chantal
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S231 - S231
  • [9] Tumour necrosis factor a −308 promoter polymorphism in patients with rheumatoid arthritis
    Zahra Rezaieyazdi
    Jalil Tavakol Afshari
    Mahnaz Sandooghi
    Farnaz Mohajer
    [J]. Rheumatology International, 2007, 28 : 189 - 191
  • [10] Polymorphism at the position -308 of TNF-α gene influences outcome of infliximab therapy in rheumatoid arthritis
    Mugnier, B
    Reviron, D
    Darque, A
    Balandraud, N
    Roudier, C
    Roudier, J
    [J]. ARTHRITIS RESEARCH & THERAPY, 2004, 6 (Suppl 1) : S23 - S24
12345